|
CFCF is pleased to announce that this E-Update is supported by Novartis Pharmaceuticals Corporation |  Follow us on Twitter!
 Like us on Facebook!
Visit us on YouTube!
|
(submitted 7/18/11)
CFCF is honored to present Survivor Stories. They reflect remarkable courage and determination. Thank you to our Survivors for sharing their courage and words of hope with other patients.
|
|
Join Us for a Cure
Make a difference and get involved with CFCF! Unite, meet fellow members of the carcinoid community, and spread awareness at upcoming CFCF events! |
Give hope and a future to neuroendocrine tumor patients: donate to CFCF where 100% of all individual donations go to carcinoid and related neuroendocrine tumor research. CFCF is a 501(c)(3) organization-all contributions are tax-deductible. We want our donors to know that we are allocating their donations responsibly and wisely to achieve a carcinoid cure as quickly as possible.
To learn more, view CFCF's:
Audited Financial Statements
IRS Form 990
|
CFCF meets all 20 Wise Giving Alliance standards for charity accountability established by the Better Business Bureau. Click here to check out the CFCF Wise Giving Report. |
|
|
|
|
|
|
Now Available: Stanford Patient Event Agenda
The Caring for Carcinoid Foundation and Stanford University are proud to release the agenda for our second annual Neuroendocrine Tumor Patient Education Conference on September 10, 2011.
This year's exciting and interactive conference includes panels and presentations that will address key issues for both patients and caregivers, ranging from "Hot Topics in Care" to "Psycho-social Aspects of Advanced Disease." More information is available on our website.
Make sure to register now for what is shaping up to be our biggest event yet! |
|
Grant Deadline Extended for NET Researchers
 Attention, young researchers! The North American Neuroendocrine Tumor Society (NANETS) will be awarding two Early Career Development Awards for the coming year. Grants will be awarded for a one-year term, in the amount of $50,000. The deadline has been extended to August 8, 2011.
Applicants for this award must have a mentor and should be either completing their training or in the first five years of a faculty appointment. Projects with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors are encouraged.
Specific areas of interest include neuroendocrine tumor epidemiology, evaluation of novel treatment strategies, and translational research projects with clear clinical implications.
Detailed application information can be found here.
Please submit applications to the North American Neuroendocrine Tumor Society by August 8, 2011. Decisions on funding will be made by September 16, 2011.
|
|
Announcing CFCF's New Educational Brochure
 Hot off the presses!
The Caring for Carcinoid Foundation has just released a new informational brochure.
Published in July 2011, this brochure, Imagine a World Without Cancer, is designed for a non-scientific audience. It offers a clear and compelling view of personalized medicine and its use in the treatment of carcinoid and related neuroendocrine cancers.
This and other educational resources are available on CFCF's website.
|
|
New Tool to Help Compare Health Providers
 Finding a good doctor can be a difficult task. Locating a physician well-versed in treating carcinoid, pancreatic neuroendocrine, and other related cancers can be even more of a challenge!
Since 2006, CFCF has offered its Doctor Database, a user-friendly tool featuring neuroendocrine specialists recommended by your fellow patients. Click here to add your favorite physician.
Now, the Robert Wood Johnson Foundation has created a new tool that allows users to compare the quality and cost of health care providers across the United States. Scroll over a map of the country to find nearly 200 free performance reports on physicians and hospitals. The Comparing Health Care Quality: A National Directory website is extremely useful for empowering patients to take initiative in seeking out the highest-quality care available.
This and other useful links are available under "Additional Resources" on CFCF's website.
|
|
|
|
|
